Consistently, previous studies have found that the interaction between SPP1+ TAMs and fibroblasts contributes to the formation of a tumor immune barrier, promotes the accumulation of ECM structures, and is important for the efficacy of immunotherapy (30). The gene discussed is SPP1; the disease is neoplasm.